Literature DB >> 7539209

Mutations in the SLC3A1 transporter gene in cystinuria.

E Pras1, N Raben, E Golomb, N Arber, I Aksentijevich, J M Schapiro, D Harel, G Katz, U Liberman, M Pras.   

Abstract

Cystinuria is an autosomal recessive disease characterized by the development of kidney stones. Guided by the identification of the SLC3A1 amino acid-transport gene on chromosome 2, we recently established genetic linkage of cystinuria to chromosome 2p in 17 families, without evidence for locus heterogeneity. Other authors have independently identified missense mutations in SLC3A1 in cystinuria patients. In this report we describe four additional cystinuria-associated mutations in this gene: a frameshift, a deletion, a transversion inducing a critical amino acid change, and a nonsense mutation. The latter stop codon was found in all of eight Ashkenazi Jewish carrier chromosomes examined. This report brings the number of disease-associated mutations in this gene to 10. We also assess the frequency of these mutations in our 17 cystinuria families.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539209      PMCID: PMC1801089     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  20 in total

1.  Cloning of a rat kidney cDNA that stimulates dibasic and neutral amino acid transport and has sequence similarity to glucosidases.

Authors:  R G Wells; M A Hediger
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  Expression cloning of a cDNA from rabbit kidney cortex that induces a single transport system for cystine and dibasic and neutral amino acids.

Authors:  J Bertran; A Werner; M L Moore; G Stange; D Markovich; J Biber; X Testar; A Zorzano; M Palacin; H Murer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  Clinical features and management of cystinuria.

Authors:  P J Dahlberg; S B Kurtz; D M Wilson; L H Smith
Journal:  Mayo Clin Proc       Date:  1977-09       Impact factor: 7.616

4.  Illegitimate transcription: transcription of any gene in any cell type.

Authors:  J Chelly; J P Concordet; J C Kaplan; A Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Massachusetts metabolic disorders screening program. I. Technics and results of urine screening.

Authors:  H L Levy; P M Madigan; V E Shih
Journal:  Pediatrics       Date:  1972-06       Impact factor: 7.124

6.  [A simple thin layer chromatography screening test for the detection of hyperaminoacidemias].

Authors:  F Kraffczyk; R Helger; H Lang
Journal:  Z Klin Chem Klin Biochem       Date:  1970-09-08

7.  Jewish diseases and origins.

Authors:  A G Motulsky
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

8.  Rapid transfer of DNA from agarose gels to nylon membranes.

Authors:  K C Reed; D A Mann
Journal:  Nucleic Acids Res       Date:  1985-10-25       Impact factor: 16.971

9.  Cystinuria: biochemical evidence for three genetically distinct diseases.

Authors:  L E Rosenberg; S Downing; J L Durant; S Segal
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

10.  Normal coding sequence of insulin gene in Pima Indians and Nauruans, two groups with highest prevalence of type II diabetes.

Authors:  N Raben; F Barbetti; A Cama; M A Lesniak; S Lillioja; P Zimmet; S W Serjeantson; S I Taylor; J Roth
Journal:  Diabetes       Date:  1991-01       Impact factor: 9.461

View more
  16 in total

1.  Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection.

Authors:  Neil Risch; Hua Tang; Howard Katzenstein; Josef Ekstein
Journal:  Am J Hum Genet       Date:  2003-02-24       Impact factor: 11.025

2.  Urinary excretion of total cystine and the dibasic amino acids arginine, lysine and ornithine in relation to genetic findings in patients with cystinuria treated with sulfhydryl compounds.

Authors:  Erik Fjellstedt; Lotta Harnevik; Jan-Olof Jeppsson; Hans-Göran Tiselius; Peter Söderkvist; Torsten Denneberg
Journal:  Urol Res       Date:  2003-10-25

3.  Lysosomal cystine accumulation promotes mitochondrial depolarization and induction of redox-sensitive genes in human kidney proximal tubular cells.

Authors:  Rodolfo Sumayao; Bernadette McEvoy; Philip Newsholme; Tara McMorrow
Journal:  J Physiol       Date:  2016-04-10       Impact factor: 5.182

4.  Molecular analysis of cystinuria in Libyan Jews: exclusion of the SLC3A1 gene and mapping of a new locus on 19q.

Authors:  R Wartenfeld; E Golomb; G Katz; S J Bale; B Goldman; M Pras; D L Kastner; E Pras
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

5.  The molecular basis of cystinuria: the role of the rBAT gene.

Authors:  M Palacín; C Mora; J Chillarón; M J Calonge; R Estévez; D Torrents; X Testar; A Zorzano; V Nunes; J Purroy; X Estivill; P Gasparini; L Bisceglia; L Zelante
Journal:  Amino Acids       Date:  1996-06       Impact factor: 3.520

6.  Evidence suggesting that the minimal functional unit of a renal cystine transporter is a heterodimer and its implications in cystinuria.

Authors:  S S Tate
Journal:  Amino Acids       Date:  1996-06       Impact factor: 3.520

7.  Cloning and functional expression of a cDNA from rat jejunal epithelium encoding a protein (4F2hc) with system y+L amino acid transport activity.

Authors:  S Y Yao; W R Muzyka; J F Elliott; C I Cheeseman; J D Young
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

Review 8.  Pathophysiology and treatment of cystinuria.

Authors:  Josep Chillarón; Mariona Font-Llitjós; Joana Fort; Antonio Zorzano; David S Goldfarb; Virginia Nunes; Manuel Palacín
Journal:  Nat Rev Nephrol       Date:  2010-06-01       Impact factor: 28.314

Review 9.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 10.  Cystinuria: an inborn cause of urolithiasis.

Authors:  Thomas Eggermann; Andreas Venghaus; Klaus Zerres
Journal:  Orphanet J Rare Dis       Date:  2012-04-05       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.